Nelly Shishkova

Generex Biotechnology Corp. (OTC:GNBT) Climbs Up on Hot News

by Nelly Shishkova December 9, 2011

Generex.gifUntil July 31, Generex has not been profitable and its accumulated net loss available to shareholders totaled over $347 million. At the same time, the revenues were minimal and the company urgently needs additional capital to support its operations.

So, while hoping to receive its products approval, the future existence of GNBT continues as a going concern.

Type the characters that you see in the box (5 characters).